NAD Finds i-Health Can Support Claims for ‘BrainStrong’ DHA Supplement for Children

New York, NY – June 20, 2012 – The National Advertising Division has determined that i-Health, Inc., can support certain advertising claims for the BrainStrong DHA supplements for young children, including that claim that the product “supports brain development and function.”

NAD is an investigative unit of the advertising industry’s system of self-regulation and administered by the Council of Better Business Bureaus. As part of its ongoing monitoring program, NAD requested substantiation from i-Health for claims that included:

• “Now there’s BrainStrong with life’s DHA.  It’s the safe and natural way to give your toddler’s brain the DHA it needs.”
• “Provides an important brain nutrient lacking in most kids’ diets.”
• “Contains the same brand of DHA found in infant formula.”
• “You nurtured his brain with DHA when he was just in a crib.  Why stop now when he’s expanding his territory?”

NAD also considered the implied claim that “[a] child’s brain will not develop and function well without DHA supplementation.”

In support of its claims, the advertiser provided NAD with a number of studies on Docosahexaenoic acid (DHA) an omega-3 fatty acid, including a randomized, single-blind controlled study in which children 7 to 9 years of age were given either a placebo or a fish-based bread spread containing DHA for six months.

NAD determined that the studies, in conjunction with the significant body of research demonstrating DHA is critical for brain development in utero and during infancy, provided a reasonable basis for the claim that BrainStrong “[s]upports brain development and function” in young children.

NAD further determined that the advertiser had supported the remaining claims at issue. Finally, NAD determined that the advertising at issue did not convey the implied message that “[a] child’s brain will not develop and function well without DHA supplementation.”

i-Health, in its advertiser’s statement, said the company is pleased “NAD concluded we have substantiated the express and implied claims … .”

“As a leader in scientifically based health and nutrition products, i-Health believes advertising should be truthful and accurate, and we are committed to tailoring advertising claims to the underlying science,” the company said.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Refers Problem Pregnancy Center to the MA Attorney General and Social Platforms for Review

New York, NY – May 16, 2024 – The National Advertising Division (NAD) referred advertising claims made by Problem Pregnancy, a crisis pregnancy center, to the Massachusetts Attorney General and social media platforms after the company failed to respond to NAD's inquiry.

Read the Decision Summary
Decision

National Advertising Division Finds Certain Compostability Claims for HoldOn Bags Supported; Recommends Others be Modified or Discontinued

New York, NY – May 16, 2024 – The National Advertising Division determined that HoldOn Bags has a reasonable basis to claim that its trash bags break down in compost environments, but recommended other claims be discontinued. 

Read the Decision Summary
Decision

Following National Advertising Division Challenge Aroeve Voluntarily Discontinues Certain Claims for HEPA Air Purifiers

New York, NY – May 15, 2024 – Following a National Advertising Division challenge brought by competitor Vesync Corporation, Antadi LLC d/b/a Aroeve Direct voluntarily discontinued certain claims for its HEPA air purifiers.

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends pawTree Discontinue Salesforce Member Earnings Claims

McLean, VA – May 9, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that pawTree, LLC discontinue certain earnings claims made by salesforce members on Facebook, YouTube, TikTok, and LinkedIn.  

Read the Decision Summary